May 14, 2020 / 11:33 AM / 13 days ago

BRIEF-Galmed Pharmaceuticals Reports Q1 2020 Financial Results

May 14 (Reuters) - Galmed Pharmaceuticals Ltd:

* GALMED PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

* Q1 LOSS PER SHARE $0.29

* Q1 EARNINGS PER SHARE ESTIMATE $-0.37 — REFINITIV IBES DATA

* GALMED PHARMACEUTICALS - MAKING CERTAIN ADJUSTMENTS TO CLINICAL STAFF PAY ACCORDING TO CURRENT AND PREDICTED LEVEL OF ACTIVITY

* REDUCING DIRECTORS’ CASH FEES BY 50% FOR FIRST HALF OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below